Xintian Pharma(SZ:002873) Zheng Quan Shi Bao·2025-05-31 06:19Group 1 - A recent report has surfaced alleging that a pharmaceutical company, Guizhou Xintian Pharmaceutical Co., Ltd., is involved in bribing medical personnel, with 125 individuals from 36 medical institutions implicated in the investigation [1][2] - The Sichuan Provincial Health Commission has confirmed that 59 individuals received a total of 116,600 yuan in violation of regulations, while 50 others received reasonable compensation for academic activities totaling 46,600 yuan [1][2] - The company was established in August 1995 and went public on May 19, 2017, with its stock trading under the name Xintian Pharmaceutical and the code 002873 [3] Group 2 - In the fiscal year 2023, the company reported a revenue of 858 million yuan, representing a 10% decrease year-on-year, and a net profit attributable to shareholders of 52.32 million yuan, down 35% from the previous year [3] - The company's selling expenses amounted to 372 million yuan, reflecting a 15% decrease compared to the previous year [3]